Seattle Genetics is a biotechnology company based in Bothell, WA, focusing on the development and commercialization of innovative antibody-based therapies for the treatment of cancer. The company's research and development efforts are centered around harnessing the power of antibodies to target and destroy cancer cells.
With a commitment to advancing the field of oncology, Seattle Genetics is dedicated to improving the lives of patients by delivering cutting-edge treatments that address unmet medical needs. Through strategic partnerships and a strong pipeline of potential therapies, the company continues to make significant contributions to the fight against cancer.
Generated from their business information